| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.078 | 0.08 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.079 | 0.08 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.031 | 0.6 |